DEVELOPING A BETA-LAPAFHONE PRODRUG FOR THERAPY AGAINST NQ01-OVEREXPRESSING BREAST

$89,999FY2008Department of the ArmyDOD

The University Of Texas Southwestern Medical Center

Investigators